Tazarar da ke buɗewa Lokacin da ake samarwa ya wuce sa ido
Scaling peptide kera yana buƙatar fasaha ta hanyoyin da suka bambanta da ƙananan ƙwayoyin ƙwayoyin cuta. Kamar yadda aka ruwaito a Binciken sikelin masana'anta na Peptide Journal, Nauyin tsari da takaddun bayanai a kowane kuri'a yana da nauyi daidai gwargwado ga peptides saboda matakin matakin tsari., ƙazanta bayanan martaba, kuma dole ne a magance lafiyar ƙwayoyin cuta kowannensu da kansa - babu wata ƙima ɗaya da ta amsa duka ukun. Bayanan masana'antu sun nuna kusan 40% na CDMOs sun gamu da matsalolin daidaiton tsari-zuwa-tsari yayin canjin gram-zuwa-kilogram, bisa lafazin nazari ta Tasirin Wealth na ƙalubalen haɓaka haɓaka masana'antar peptide.
Haɗarin zurfi shine tsarin tsari maimakon fasaha. Yayin da hanyoyin sadarwar masu ba da kayayyaki ke fadada don samar da ƙarin buƙatu, ƙarin nodes masana'antu suna gabatar da ƙarin sauye-sauye, ƙarin handoffs na tsoma sarkar-na tsare, da ƙa'idodin fassarar da aka yi amfani da su ga takaddun shaida na guntun bincike. A cikin sassan kasuwannin ƙananan hukumomi, ƙayyadaddun ƙayyadaddun tsabta waɗanda za a yi la'akari da su ba su cika ba don aikin da ke kusa da asibiti an gabatar da su azaman cikakkun takaddun inganci.. Rata tsakanin abin da takarda ya ce da abin da mai duba ke buƙata yana girma - kuma ƙungiyar bincike ce ke ɗaukar sakamakon lokacin da yawa suka gaza kwatanta., yana gurɓata gwajin kwayar halitta, ko yana haifar da amsa mai kumburi a cikin samfurin in vivo.
Ka'idodin mulki guda huɗu da aka tattauna a ƙasa ba su kawar da haɗarin ba, amma suna bayar da sayayya, QC, da R&D ya haɗa wani tsari don ƙididdigewa kuma ya ƙunshi shi ba tare da la'akari da inda suka zauna a cikin zagayowar buƙata ba.
Ka'ida 1: Takaddun bayanai Dole ne su raba abin da kuke buƙata da abin da zaku karɓa
Saitin ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun tsarin gudanarwa shine mafi inganci, kuma ita ce wadda aka fi jinkirtawa. Sakamakon jinkiri shi ne ƙa'idodin sakin sun zama a bayyane - masu siyarwa sun saki ga nasu matakan., kuma ƙungiyoyin bincike sun karɓi abin da ya zo maimakon abin da suka ayyana.
Ƙa'idar mulki mai amfani ita ce a ayyana ƙayyadaddun ƙayyadaddun bayanai ta hanyar amfani kafin neman zance, ba bayan nazarin CoA ba. Don ma'aunin biochemistry na benci da aikin ɗaure in vitro, Tsaftar RP-HPLC ≥95% tare da tabbatar da yawan jama'a shine tushen tushe mai karewa ga wancan matakin na takaddun peptide.. Don ƙididdigar tushen tantanin halitta, iyakar endotoxin dole ne a bayyane - ba a fayyace shi daga tsarki ba - saboda yawan peptide zai iya wuce iyakar tsabtar HPLC kuma har yanzu yana ɗaukar isasshen lipopolysaccharide don skew karatun cytokine.. Don IND mai ba da damar ilimin harhada magunguna ko preclinical a cikin nazarin vivo, ƙayyadaddun saitin ya sake faɗaɗa: tsarki ta RP-HPLC, ainihi ta babban ƙuduri MS (ESI-TOF ko Orbitrap, daidaitattun taro <5 ppm), ragowar sauran ƙarfi ƙididdigewa, net peptide abun ciki, takardun shaida, da kuma gwajin haifuwa da gwajin endotoxin ta hanyoyin pharmacopeial.
Peptide Synthesis Aiki mai tsari mai hawa uku ya rabu:
-
Bincike-amfani-kawai (SAI) ƙayyadaddun bayanai: ganewa ta MS, tsabta ≥95% ta RP-HPLC, Peptides na roba ainihin abin da ake iya ganowa - isasshe don gano bugu da kuma duban in vitro
-
Ƙayyadaddun ci gaban tsari: Bukatun RUO tare da bayanin ƙazanta na yau da kullun ta LC-MS, sauran ƙarfi da kuma TFA counterion takardun, ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙayyadaddun ƙimar ≥97%, da kuma rubuta kwatancen duban canjin sikeli
-
GMP-madaidaicin ko ƙayyadaddun kayan aikin asibiti: ingantattun hanyoyin nazari akan ICH Q2(R2), m tsari records, sterility ta USP <71>, endotoxin na kwayan cuta ta USP <85> tare da ƙayyadaddun iyakokin yarda, samfuran tunani da aka riƙe, bita bita, da kuma takardun CAPA
Bambance-bambancen ba saboda yawancin amfani da bincike yana buƙatar kayan matakin GMP ba, amma saboda haɗakar da tiers - odar kayan RUO don ingantaccen aikin ingantaccen aiki, misali - shine ma'anar da rashin fahimta game da amfani da aka yi niyya ya zama alhaki na ka'ida da haɓakawa..
Ka'ida 2: Ganowa Yana Bukatar Fiye da Lamba Batch
Takaddun shaida na bincike wanda ya ƙunshi lamba da yawa kawai, kashi mai tsarki, kuma tabbatar da taro ba takaddar ganowa ba ce. Magana ce.
Abun iya ganowa, a tsarin mulki, yana nufin mai duba zai iya sake gina abin da aka yi, yadda aka yi, wadanne hanyoyi aka yi amfani da su, Wadanne kayan aiki aka daidaita lokacin, kuma ko kuri'a ta hadu da ƙayyadaddun da aka riga aka yarda da su - ba ƙayyadaddun ƙayyadaddun da aka yanke bayan haɗawa ba. Tsarin ALCOA na MHRA, wanda ya shafi kowane rikodin bayanan da aka tsara, ya bayyana mafi ƙarancin: dole ne bayanai su zama masu iyawa (ga mutum da kayan aiki), Mai yiwuwa, Na zamani, Na asali, kuma Daidai. A aikace, wannan taswirori akan tsarin gine-ginen CoA wanda MOL Yana Canza Haɓaka Binciken Takardun Ingancin ya bayyana a matsayin yana buƙatar buƙatun abin ganowa, raw RP-HPLC chromatograms tare da cikakkun teburin haɗin kai, babban ƙudurin sikirin MS tare da ƙaddamar da jujjuyawar jiha, da shigarwar bayyane don endotoxin da bioburden inda abin da aka yi nufin amfani ya ba su garanti.
Raw chromatograms, ba taƙaice adadin tsafta ba, sune mahimman abubuwan anan. Ƙimar taƙaitaccen kashi yana rushe yanayin hanya, ƙayyadaddun shafi, motsi-lokaci gradient, Tsawon igiyoyin UV, da dabarar haɗakarwa kololuwa cikin lamba ɗaya. Babu ɗayan wannan mahallin da za a iya dawo da shi daga lambar ita kaɗai. Lokacin da ƙungiyar ƙasa ke buƙatar warware matsalar tantancewar da ba ta yi nasara ba ko kuma ba da hujjar kwatanta-zuwa-yawa a cikin shirin yanar gizo da yawa., rashin cikakkun bayanan chromatographic yana sa waɗannan ayyuka su zama masu wahala.
Don shirye-shiryen da ke amfani da dillalai masu yawa da yawa ko waɗanda ke kan wuraren masana'anta na yanki, rikodin jerin tsare-tsaren don albarkatun kasa - resin lot tracking, Takaddun shaida na reagent na karewa, Takaddun tsabtataccen ƙarfi - su ne bambanci tsakanin takaddun ganowa da tabbatacce. Tsohon ya tsira daga binciken tsari; na karshen baya yi.
Key Takeaway: CoA mai tsaro yana sake gina tarihin kuri'a. Takaitaccen bayani CoA yana bayyana sakamakonsa ne kawai. Takaddun matakin mulki na buƙatar tsohon.
Ka'ida 3: Dole ne Gwaji ya dace don amfanin da aka yi niyya, Ba kawai Matsayin Samfur ba
Mafi mahimmancin kuskuren nazari a cikin kasuwar peptide na yanzu shine kula da tsabtar HPLC da tabbatar da yawan jama'a azaman isassun gwajin fitarwa a duk yanayin amfani.. Ba su ba.
RP-HPLC tana auna siginar UV na dangi da aka sanya zuwa babban kololuwar chromatographic ƙarƙashin saiti ɗaya na yanayin hanya.. Mass spectrometry yana tabbatar da cewa ions da aka gano sun dace da nauyin kwayoyin da ake tsammani. Tare, suka amsa: “Shin wannan kwayar halitta ta dace da jerin da aka yi niyya, kuma shine babban bangaren ta hanyar amsawar UV?” Ba sa amsa tambayoyi game da ƙarfi, haihuwa, Endotoxin load, kwanciyar hankali, net peptide abun ciki, ko kuma asalin ƙazantattun ƙazantattun abubuwa waɗanda ke ɗaukar rauni a 214 nm.
Ga kowane peptide da aka yi nufin al'adar tantanin halitta, ex vivo aikin nama, ko in vivo gwamnati, Gwajin endotoxin wani nau'i ne na gwaji na musamman. Farashin LAL (Limulus Amebocyte Lysate) chromogenic ko turbidimetric assay ta USP <85> kai tsaye yana auna ƙwayar endotoxin na kwayan cuta da rahotanni a cikin EU/MG ko EU/ml. Kamar yadda Abubuwan da aka kirkira na Proteomics akan endotoxin da gwajin haifuwa don peptides na bincike takardu, gurɓataccen endotoxin na iya ci gaba ko da lokacin da tsabtar chromatographic ya yi girma, saboda lipopolysaccharide gutsuttsura daga gram-korau kwayoyin ganuwar ba a cire ta daidaitaccen RP-HPLC tsarkakewa.. Iyakoki na yau da kullun a cikin wallafe-wallafen sun fito daga <0.1 EU/mg don ƙididdigar tushen tantanin halitta zuwa <5 EU/mg don amfanin bincike na gaba ɗaya, tare da m iyaka (<0.25 EU/ml ko <5 EU/kg/hr-daidaita kashi) don aikace-aikacen parenteral. Samuwar Peptide
Gwajin haihuwa akan USP <71> - Tsarin al'ada na kwanaki 14 a cikin Fluid Thioglycollate Medium da Soybean-Casein Digest Medium - yana amsa wata takamaiman tambaya.: ko akwai kwayoyin halitta masu amfani. Kuri'a na peptide na iya zama bakararre (babu kwayoyin halitta) kuma har yanzu suna ɗaukar nauyin pyrogenic endotoxin wanda ya isa ya haifar da amsawar kumburin tsarin. Gwaje-gwajen guda biyu sun cika, ba maye ba.
Ka'idar mulki ita ce ayyana kwamitin gwaji daidai da yanayin amfani, sa'an nan kuma buƙatar takaddun kowane gwaji da kansa, maimakon barin tsarki ya zama wakili don aminci. The Canje-canjen MOL Bayan Jagorar tantancewa na gwaji na CoA yana ba da tsari mai haɗaɗɗiyar haɗari wanda ke ba da wajibi, na zaɓi, da buƙatun tabbatarwa na ɓangare na uku ta yanayin aikace-aikacen - samfuri mai amfani don ƙungiyoyin sayayya suna gina ƙa'idodin cancantar mai siyarwa.
Don shirye-shiryen da ke canzawa daga nunawa zuwa aikin IND, Tabbatar da hanyar ICH Q2(R2) don duk ƙididdiga masu mahimmanci na saki shine madaidaicin fasaha wanda ke raba dacewa-da-manufa daga dacewa-don-bayani.. Hanyoyi masu inganci sun haɗa da ƙayyadaddun ƙa'idodin dacewa da tsarin, linearity da kewayon bayanai, takamaiman takardun shaida, da sharuɗɗan karɓa na yau da kullun. Hanyoyin da ba a tabbatar da su ba sun kasance masu cancanta a mafi kyau - isassun abubuwan bincike, amma ba za a iya karewa don ƙaddamar da tsari ba.
Ka'ida 4: Mulkin Sadarwa Yana Hana Da'awar hauhawar farashin kayayyaki
Lokacin da samar da peptide ke tsiro ta hanyar cakuduwar tashoshi da ba a kayyade ba, nisa tsakanin abin da takaddun ya tabbatar da abin da ke da'awar tallace-tallacen yana karuwa. Wannan ba ƙaramin batun sadarwa ba ne; alhaki ne na ƙasa ga duka mai kaya da ƙungiyar bincike waɗanda suka dogara da da'awar.
Babban tsaftar RP-HPLC da kuma tabbatar da yawan jama'a ba sa tabbatar da amincin asibiti, warkewa inganci, ko dacewa don amfani da haƙuri. Sun tabbatar da cewa kuri'a na ƙunshe da wani fili wanda ya yi daidai da tsarin da aka yi niyya da kuma cewa fili shine babban sashi a ƙarƙashin hanyar nazari ɗaya.. Kamar yadda aka ambata a cikin nazarin pepguide na gwajin tsaftar peptide da fassarar CoA, ba sakamakon shi kadai ke tabbatar da karfi, haihuwa, kula da endotoxin, kwanciyar hankali, ko dacewa don amfani da aka tsara.
Ma'auni mai amfani don sadarwar alhakin shine:
-
Takaddun darajar bincike goyon baya: “Wannan kayan yana da tsarin da aka nufa, ya sadu da ƙayyadaddun tsabta, kuma ya dace da aikace-aikacen dakin gwaje-gwaje da aka bayyana."
-
Takaddun darajar GMP goyon baya: “An kera wannan kayan a ƙarƙashin ingantattun sharuɗɗa, ya sadu da ƙayyadaddun sakin da aka riga aka yarda, kuma ana iya gano shi daga ɗanyen abu zuwa ƙuri'a da aka fitar."
-
Babu wani matakin da ke goyan bayan: “Wannan kayan yana da aminci ga gudanar da ɗan adam, yana da tasiri a kashi da aka ba, ko kuma an nuna shi don magance ko hana kowane irin yanayi."
Wannan bambance-bambancen yana da mahimmanci ga ƙungiyoyin bincike saboda ƙetare da'awar masu siyarwa na iya gabatar da zaɓin zaɓi a cikin cancantar mai siyarwa.. Idan takaddun mai siyarwa yana nuna faffadan ɗaukar hoto fiye da yadda gwaje-gwajen suka bayar a zahiri, ƙungiyar bincike na iya tsallake matakan tabbatarwa masu zaman kansu waɗanda in ba haka ba zasu zama wani ɓangare na ƙa'idar ingancin su. The MOL Yana Canza nazarin amincin peptide na lafiyar lafiyar waya, wanda ya ƙunshi ƙa'idodin karɓa na tsari don haɗaɗɗen peptides masu allura ciki har da USP <71> sterility da USP <85> matakin endotoxin, yana da ilimantarwa a matsayin nuni ga yadda ingantaccen rubuce-rubucen ingancin ya yi kama da kowane matakin.
⚠️ Gargadi: CoA wanda ke ba da rahoton tsabta da taro ba tare da bayanan endotoxin ba, hali na haihuwa, ko yanayin hanya yana ba da ingantaccen bayani mai inganci, ba m ingancin tabbacin. Yi la'akari da shi azaman mafari don tattaunawar mai siyarwa, ba yanke shawarar saki ba.
Gina Ingantacciyar Mulki Mai Ma'auni
Ka'idodin huɗun da ke sama ba jerin gwano ba ne - sun dogara da juna, da tsarin ingantaccen tsarin mulki na peptide wanda ya magance ɗaya ko biyu kawai daga cikinsu zai sami giɓi wanda zai iya samun ingantaccen matsin lamba.. Share bayanai dalla-dalla suna fitar da abin da ake buƙata gwaji. Takaddun da za a iya ganowa suna ɗaukar abin da gwajin da aka yi. Gwajin dacewa da manufa yana tabbatar da ko an cika ƙayyadaddun bayanai. Sadarwar da ke da alhakin tana tabbatar da cewa abin da takaddun ya ce shine abin da masu ruwa da tsaki suka fahimta.
Maganin tsarin shi ne matakan inganci masu inganci tare da ƙayyadaddun ƙa'idodin miƙa mulki. Abubuwan amfani da bincike an haɗa su kuma an sake su akan ma'aunin RUO. Lokacin da shirin ya canza zuwa aiwatar da haɓakawa, motsa jiki kwatankwacin yana tabbatar da cewa sabon kuri'a ya cika ƙayyadaddun ƙayyadaddun ƙayyadaddun saiti kafin a yi amfani da kayan don nazarin vivo.. Lokacin da shirin ya ci gaba zuwa aikin IND, hanyar tabbatarwa, m tsari records, kuma gwajin harhada magunguna yana kan wurin kafin a fitar da kuri'a na farko na GMP - ba a matsayin motsa jiki ba., amma saboda nauyin daftarin aiki a wancan lokacin yana bin masu dubawa da kwamitocin da'a, ba na tilas ba.
Yayin da sarƙoƙin samar da kayayyaki ke yaɗuwa cikin sassan ƙasa don biyan buƙatun duniya, Tsarin tsari na APAC musamman yana haɗuwa zuwa tsauraran buƙatun takaddun, kamar yadda aka rufe MOL Canje-canje' nazarin APAC GMP tightening da peptide wadata sarkar. Shirye-shiryen cancantar masu samar da kayayyaki waɗanda ke kula da bita na CoA a matsayin matakin hawan jirgi na lokaci ɗaya - maimakon ci gaba da duba takamaiman takamaiman bayanai - su ne shirye-shiryen da aka fi fallasa lokacin da yanayin buƙatu ke haifar da ƙarancin wadata da kuma jarabar karɓar takaddun ƙayyadaddun bayanai yana ƙaruwa..
Don ƙungiyoyin da ke kimanta abokan haɗin gwiwa, tsare-tsaren ci gaba da tallace-tallace aikin mulki ne, ba saukin siyayya ba. Ayyukan da aka zayyana a cikin gina ci gaban mai siyar da peptide kafin nazarin ku na gaba - ƙwararrun masu ba da tallafi akan gwajin ainihi, takardun shaida, batch traceability, da kuma canza iko kafin a buƙaci su - su ne bayanin aiki na ka'idar cewa dole ne a gina gwamnati kafin bukata, ba a mayar da martani ga gazawar.
Canje-canjen MOL yana haɗa al'ada da peptides na kasida a cikin Class 100 muhallin tsafta, tare da daidaitattun takaddun fitarwa waɗanda suka haɗa da takamaiman takamaiman nau'ikan RP-HPLC chromatograms da babban sikelin MS., da gwajin haifuwa da gwajin endotoxin da ake samu akan buƙatun al'adun tantanin halitta da aikace-aikacen vivo - haɗin da ka'idodin mulkin da ke sama suka ayyana ya dace da bincike da yin amfani da shi daidai..
Mulki Shine Mai Ba da Mulki, Ba Overhead ba
Hujjar cewa ingantacciyar shugabanci ita ce tsada mai tsadar gaske wanda yakamata a jinkirta har sai shirin ya kai matakin asibiti ba ya tsira daga binciken idan aka bincika a matakin kuri'a.. Batch ɗin da ya gaza gwajin endotoxin bayan binciken in vivo ya riga ya shiga, aikin haɗin gwiwa wanda ba za a iya maimaita shi ba saboda ba a rubuta yanayin hanyar ba, ko gazawar kwatantawa da yawa da yawa wanda ke jinkirta lokaci da makonni takwas - kowane ɗayan waɗannan sakamako ne mafi tsada fiye da saka hannun jarin da zai hana shi..
Bukatar Peptide za ta ci gaba da girma. Ƙwararrun kasuwannin da ke tafiyar da haɓakar haɓakar tsari ne, ba zagaye ba. Tsarin mulki wanda ke tallafawa abin dogaro, Amfani mai kariya na kayan peptide ba zai haɗa kai ba a ƙarƙashin matsa lamba. Suna buƙatar takamaiman takamaiman abin da ake buƙata da gangan, da gangan takardun abin da aka yi, da gangan zaɓin gwaje-gwaje daidai da amfani da aka yi niyya, da kamewa da gangan game da abin da ainihin takaddun ya tabbatar.
Ƙungiyoyin da suka gina waɗannan tsare-tsare kafin sake zagayowar tiyata na gaba za su kasance mafi kyau a matsayi - a cikin sake fasalin, a cikin shirye-shiryen tsari, kuma a cikin amintattun alaƙa tare da masu haɗin gwiwa da masu bita waɗanda ingantattun takardu ke haifarwa akan lokaci.
Idan shirin ku yana gabatowa wani mataki kuma kuna buƙatar takamaiman fakitin bayanai ko tattaunawa ta yuwuwar fasaha don haɗaɗɗiyar gyare-gyare ko buƙatun masana'anta mara kyau., tuntuɓi ƙungiyar fasaha Canje-canje na MOL don tantance waɗanne takardu da bayanan gwaji na rukunin ku na gaba ke buƙata.
